Viking Holdings (NYSE:VIK) reported a surge in full-year profitability on Tuesday, bolstered by an aggressive fleet expansion and a luxury travel boom that has already filled the vast majority of its 2026 sailing schedule.
Best Buy (NYSE:BBY) reported fourth-quarter earnings that cleared Wall Street’s profitability hurdles on Tuesday, though a slight revenue miss highlighted the continued caution of consumers regarding big-ticket electronics.
AutoZone (NYSE:AZO) reported an 8.1% increase in second-quarter sales on Tuesday, as the company’s aggressive store expansion and inflation-driven pricing offset a dip in net income caused by technical accounting charges.
Kontoor Brands (NYSE:KTB) posted a sharp increase in fourth-quarter revenue on Tuesday, clearing the $1 billion threshold as the company reaps the benefits of its 2025 acquisition of Helly Hansen and continued momentum in its core denim business.
Sea Limited (NYSE:SE) capped a transformative fiscal year with a massive jump in bottom-line growth, signaling that the Southeast Asian internet giant has successfully pivoted from cash-burning expansion to a sustainable, high-margin model.
Target (NYSE:TGT) posted a solid fourth-quarter performance on Tuesday, as the big-box retailer leaned into its digital marketplace and subscription services to offset a broader slowdown in discretionary consumer spending.
Civeo (NYSE:CVEO) reported a significant improvement in its quarterly bottom line and a jump in cash flow, as aggressive cost-reduction efforts in Canada and a strategic expansion in Australia began to pay off.
Thor Industries (NYSE:THO) reported a return to profitability in its fiscal second quarter, bolstered by strong motorized RV demand, while simultaneously moving to dismantle its long-standing decentralized business model in North America.
Hycroft Mining Holding (NASDAQ:HYMC) revealed a substantial expansion of its precious metals deposit on Tuesday, coupled with a strengthened liquidity position that places the developer among the few debt-free juniors in the sector.
Esperion Therapeutics (NASDAQ:ESPR) moved to significantly broaden its cardiovascular portfolio on Tuesday, announcing a deal to acquire privately held Corstasis Therapeutics and its first-of-its-kind nasal spray for heart failure-related edema.
Flowco Holdings completed its acquisition of Valiant Artificial Lift Solutions on Tuesday, a $200 million move that significantly broadens its technology portfolio in the high-stakes Permian Basin.
Greenwich LifeSciences (NASDAQ:GLSI) surged ahead in its clinical timeline on Tuesday, reporting a significant acceleration in patient recruitment for its pivotal Phase III breast cancer study.
